Dr. Soumya Basu | RNA Biology Function | Women Researcher Award
Dr. Soumya Basu , Dr. D. Y. Patil Biotechnology and Bioinformatics Institute , India
Dr. Soumya Basu, an Associate Professor and Principal Investigator at the Cancer and Translational Research Centre, Dr. D.Y. Patil Biotechnology Institute, Pune, boasts 18+ years of experience in life sciences. With a Ph.D. from Jadavpur University and expertise in cell culture, nc-RNA research, small molecule design, and drug-resistant cancer therapy, Dr. Basu is a recognized leader in cancer research. She has contributed extensively to research, scientific writing, and mentoring, with a strong track record in publications, book chapters, and protocols. Her experience spans academic positions, including roles at the Tata Memorial Centre and Chittaranjan National Cancer Institute. Dr. Basu is committed to exploring the molecular mechanisms of cancer and developing innovative therapeutic strategies, with a focus on natural product analogs and drug delivery systems targeting metastatic cancers. Her research continues to impact the understanding and treatment of cancer at a molecular level.
Publication Profile:
Strengths for the Award:
-
Extensive Research Experience: Dr. Soumya Basu brings over 18 years of research experience in life sciences, with a strong focus on cancer research, small molecule design, nc-RNA research, and drug delivery systems. Her expertise in animal cell culture, cell-based assays, and molecular biology techniques demonstrates her ability to drive impactful research.
-
Significant Academic Contribution: As a Principal Investigator at the Cancer and Translational Research Centre, Dr. Basu has made notable contributions in the area of targeted cancer therapies. Her involvement in high-impact publications, including recent journal articles and book chapters, highlights her active role in advancing scientific knowledge.
-
Leadership and Mentorship: As an Associate Professor, Dr. Basu has shown a commitment to leadership, team management, and mentoring students and researchers. Her role as a mentor and ability to manage cross-functional teams demonstrate strong organizational and leadership skills.
-
Scientific Writing and Publishing: Dr. Basu’s contributions to scientific literature are extensive, with multiple publications in peer-reviewed journals and book chapters. Her work on drug discovery, biomaterials, and the application of AI in drug development further illustrates her versatility and scientific rigor.
-
Innovative Research Areas: Dr. Basu is involved in cutting-edge research areas, such as the development of natural product analogs targeting the PPAR pathway in lung carcinoma, and the design of drug delivery systems to target metastatic lymph nodes in breast cancer. Her research has the potential for significant clinical impact.
-
Educational Background: Dr. Basu’s academic qualifications, including a Ph.D. in Life Sciences, an advanced PG course in Artificial Intelligence and Machine Learning, and an advanced diploma in Medical Writing and Regulatory Affairs, showcase her diverse skill set and adaptability to evolving scientific fields.
Areas for Improvement:
-
Broadening Research Scope: While Dr. Basu’s focus on cancer research and small molecules is impressive, expanding her research into broader therapeutic areas or exploring more interdisciplinary fields could further strengthen her profile as a researcher. Her expertise in AI and machine learning could be leveraged further to address other diseases or health-related issues, potentially opening up new avenues for impactful research.
-
Increase Collaborative Opportunities: While she has worked with prominent researchers, increasing international collaborations, especially in fields like artificial intelligence in biomedical research, could enhance the global impact of her work and broaden her professional network.
-
Public Engagement and Outreach: Dr. Basu could focus on increasing public outreach and raising awareness of her research. Given her significant contributions, engaging with non-scientific audiences, through media interviews, science communication platforms, or public talks, could further highlight her as a thought leader.
Education:
Dr. Soumya Basu holds a Ph.D. in Life Sciences from Jadavpur University, where her thesis explored “Reactive oxygen species-mediated targeted therapy in drug-resistant cancer.” She furthered her academic journey with an advanced PG course in Artificial Intelligence and Machine Learning from the University of Texas at Austin, where she earned a 90% score. Dr. Basu also completed an Advanced Diploma in Medical Writing and Regulatory Affairs from Syncorp Educational Institution in Bangalore. She earned her M.Sc. in Microbiology from the University of Kalyani with a 65.6% mark and her B.Sc. (Hons.) in Physics, Chemistry, and Mathematics from the University of Burdwan. Dr. Basu’s educational background showcases a blend of biological sciences and interdisciplinary learning, equipping her with the necessary skills to tackle complex challenges in cancer research and translational medicine.
Experience:
Dr. Soumya Basu has built an illustrious academic and research career. Currently, she is an Associate Professor and Principal Investigator at Dr. D.Y. Patil Biotechnology Institute, Pune, where she has been since 2014. Dr. Basu’s academic journey includes significant roles in research, including her tenure as a Research Associate at the Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai. Her work at Chittaranjan National Cancer Institute, Kolkata, as a Senior Research Fellow (ICMR), honed her skills in cancer biology and cellular chemotherapy. Additionally, she served as a Project Assistant at Jadavpur University and the University of Calcutta, gaining foundational research experience. Her early career also included a position as a Lecturer at Kulti College. Dr. Basu’s multifaceted experience allows her to mentor students, manage cross-functional teams, and spearhead research projects in cancer and drug delivery systems.
Awards and Honors:
Dr. Soumya Basu’s dedication to research excellence has earned her numerous accolades. Her work in cancer research has led to high-impact publications in prestigious journals, with citations exceeding 550 and an H-index of 14. Dr. Basu’s expertise in drug design, nc-RNA research, and cell-based assays has contributed to the development of novel therapeutic approaches in cancer treatment. Her research collaborations have resulted in successful international publications, particularly in drug discovery and cancer genomics. Additionally, she has received recognition from academic and research institutions for her contributions to the field of cancer and biotechnology. Although specific awards are not listed, Dr. Basu’s consistent publication record and leadership in cutting-edge research demonstrate her significant influence in her field. Her recognition among peers and scientific communities highlights her as a key figure in advancing translational medicine and cancer therapy.
Research Focus:
Dr. Soumya Basu’s research primarily focuses on the molecular mechanisms of cancer and the development of innovative therapies. Her work emphasizes the design and synthesis of natural product analogs targeting the PPAR pathway in lung carcinoma and other cancers. Dr. Basu is passionate about advancing drug delivery systems, particularly those targeting metastatic lymph nodes in breast cancer. Her research also delves into non-coding RNAs (ncRNAs), exploring their roles in cancer biology and therapeutic potential. A significant portion of her work is dedicated to studying drug-resistant cancers and designing targeted therapies to overcome resistance. She is involved in both basic and applied research, aiming to develop novel, more effective cancer treatments. Dr. Basu’s interdisciplinary approach integrates artificial intelligence and machine learning techniques with biotechnological applications, positioning her as a forward-thinking scientist at the intersection of computational and experimental cancer research.
Publications Top Notes:
- miRVim: Three-dimensional miRNA Structure Database (2024) 🧬📚
- Novel insights on oral squamous cell carcinoma management using long non-coding RNAs (2024) 🦷💉
- Design, Docking, Synthesis, and In vitro Evaluation of Potent Anti-tubercular Agents Targeting DNA Gyrase (2024) 💊🧪
- Identification of Novel PPAR-β/δ Agonists from Kaempferol, Quercetin, and Resveratrol Derivatives by Targeting Cancer (2024) 🍇💥
- Exploring binding mode assessment of novel kaempferol, resveratrol, and quercetin derivatives with PPAR-α as potent drug candidates against cancer (2023) 🌿🔬
- Design, Synthesis, and Biological Evaluation of Novel Quercetin Derivatives as PPAR‐γ Partial Agonists by Modulating EMT in Lung Cancer (2023) 🍃🫀
- Partial Activation of PPAR‐γ by Synthesized Quercetin Derivatives Modulates TGF‐β1‐Induced EMT in Lung Cancer Cells (2023) 💊🧬
- Synergistic combination of ritonavir and cisplatin as an efficacious therapy in human cervical cancer cells (2023) 💊🤝
- Non-Coding RNAs in Oral Cancer: Emerging Roles and Clinical Applications (2023) 💉🧬
Conclusion:
Dr. Soumya Basu is a highly deserving candidate for the Research for Women Researcher Award. Her substantial research contributions, leadership roles, and innovative work in the cancer research field, particularly in drug discovery and therapeutic design, make her a standout candidate. Dr. Basu’s scientific rigor, ability to manage and mentor, and her commitment to advancing medical science position her as a leader in her field. Despite areas for further growth, particularly in expanding the scope of her research and increasing public engagement, Dr. Basu’s exemplary career trajectory, mentorship, and active research contributions make her an outstanding nominee for this prestigious award.